相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Structure-based development of human antibody cocktails against SARS-CoV-2
Nan Wang et al.
CELL RESEARCH (2021)
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Paul-Albert Koenig et al.
SCIENCE (2021)
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Jiwan Ge et al.
NATURE COMMUNICATIONS (2021)
Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e
Kathryn E. Kistler et al.
ELIFE (2021)
Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
Saathvik R. Kannan et al.
JOURNAL OF AUTOIMMUNITY (2021)
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Wanwisa Dejnirattisai et al.
CELL (2021)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Daming Zhou et al.
CELL (2021)
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney et al.
CELL HOST & MICROBE (2021)
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
Gabriele Cerutti et al.
CELL HOST & MICROBE (2021)
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Ester C. Sabino et al.
LANCET (2021)
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang et al.
NATURE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear et al.
CELL REPORTS (2021)
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann et al.
CELL (2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications
Salim S. Abdool Karim et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
S. A. Madhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
William N. Voss et al.
SCIENCE (2021)
A human coronavirus evolves antigenically to escape antibody immunity
Rachel T. Eguia et al.
PLOS PATHOGENS (2021)
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic
Sarah P. Otto et al.
CURRENT BIOLOGY (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum et al.
SCIENCE (2021)
Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021
Catherine M. Brown et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
Sarah Cherian et al.
MICROORGANISMS (2021)
Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV
Wen Jiang et al.
MABS (2021)
Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
Romain Rouet et al.
MABS (2021)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
CoV-AbDab: the Coronavirus Antibody Database
Matthew I J Raybould et al.
BIOINFORMATICS (2020)
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
Shuo Du et al.
CELL (2020)
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli et al.
CELL (2020)
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Daming Zhou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
Johanna Hansen et al.
SCIENCE (2020)
Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
Zhe Lv et al.
SCIENCE (2020)
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan et al.
SCIENCE (2020)
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes et al.
NATURE (2020)
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici et al.
SCIENCE (2020)
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Hejun Liu et al.
IMMUNITY (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Antibody Immunodominance: The Key to Understanding Influenza Virus Antigenic Drift
Meghan O. Altman et al.
VIRAL IMMUNOLOGY (2018)
GISAID: Global initiative on sharing all influenza data - from vision to reality
Yuelong Shu et al.
EUROSURVEILLANCE (2017)
Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope
Luke N. Robinson et al.
CELL (2015)
Networks link antigenic and receptor-binding sites of influenza hemagglutinin: Mechanistic insight into fitter strain propagation
Venkataramanan Soundararajan et al.
SCIENTIFIC REPORTS (2011)
PyRosetta: a script-based interface for implementing molecular modeling algorithms using Rosetta
Sidhartha Chaudhury et al.
BIOINFORMATICS (2010)